Maharashtra on Thursday it reported 3,880 frescoes COVID-19 cases. Now, the state is home to 60,905 active patients. However, the state also recorded 4,358 recoveries in the last 24 hours, bringing the total to 17,74,255. Maharashtra’s patient recovery rate is currently 94.14 percent. Here are some of the other highlights …
Read More »70-80 pc reduction in participation in the COVAXIN trial: AIIMS physician
By Priyanka Sharma ANI | Updated: Dec 16 2020 21:00 IST New Delhi [India], Dec 16 (ANI): With the start of Covid vaccination, an immediate future in India, the phase III clinical trial for Bharat Biotech’s locally developed COVAXIN vaccine candidate is witnessing a shortage of volunteer participation, with a …
Read More »Covaxin Phase 1 Trial Result Shows Strong Immune Response and Mild Adverse Events
Hyderabad-based Bharat Biotech on Wednesday released the results of phase 1 trials of its coronavirus (Covid-19) vaccine ‘Covaxin’, which produced a robust immune response against the disease and showed that most of the adverse events were mild and resolved. The vaccine is stored between 2 and 8 degrees Celsius and …
Read More »Covaxin Produces Strong Immune Response Without Serious Adverse Effects, Phase 1 Results Show
By: Express Web Desk | New Delhi | Updated: December 16, 2020 8:58:24 pm Prime Minister Narendra Modi receives briefing during a visit to the Bharat Biotech facility (archive) The Covid-19 vaccine indigenously developed by Bharat Biotech has been found to be well tolerated in all dose groups with no …
Read More »No serious adverse events were found, the Bharat Biotech phase 1 result shows
India’s first indigenous Covid-19 vaccine, Covaxin, developed by Bharat Biotech in partnership with the Medical Research Council of India, was found to be “well tolerated in all dose groups with no serious vaccine-related adverse events “stated the interim findings from the phase 1 trial of Covaxin. The data also indicate …
Read More »Covaxin induced a robust immune response in phase 1 trials: Bharat Biotech | India News
HYDERABAD: India’s first indigenous vaccine, Covaxin, managed to induce a robust immune response without any serious adverse events during phase 1 trials that were conducted on 375 volunteers, Bharat Biotech said in a research article. The company said that most of the adverse events seen during the study were mild …
Read More »Covaxin triggers immune response, no adverse effects in phase 1 trial
Covaxin is a candidate for an indigenously developed coronavirus vaccine (archive) New Delhi: Covaxin, which is one of three coronavirus vaccine candidates being considered for emergency use authorization in India, induced an immune response and did not record any serious adverse events, the company said Wednesday night when publishing the …
Read More »Haryana Health Min Anil Vij, who has COVID-19, in critical condition
The minister is admitted to the Medanta Hospital of Gurugram. Haryana Health Minister Anil Vij, who is currently battling the COVID-19 infection, was admitted to Gurugram’s Medanta Hospital on Tuesday in critical condition, authorities said. The minister is undergoing treatment with Dr. Sushila Kataria, senior director of Medanta’s Department of …
Read More »66 students, 5 staff members at IIT-Madras test positive for coronavirus
The institute had opened its doors for seniors on December 7 according to an order from the state government. Seventy-one residents of the Indian Institute of Technology Madras (IIT-M) tested positive for coronavirus. This includes 66 students. After this, the institute closed its laboratories, library and departments. The institute opened …
Read More »Anil Vij complains of discomfort, switched to PGIMS from Rohtak
By: Express News Service | Chandigarh | December 13, 2020 8:49:55 pm Haryana Health Minister Anil Vij, who tested positive for Covid-19 on December 5, was transferred to the Postgraduate Institute of Medical Sciences in Rohtak from Ambala civil hospital. (Archive) Haryana Health Minister Anil Vij, who tested positive for …
Read More »